Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.22.2.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 06, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Securities Financing Transaction [Line Items]          
Capital contribute       $ 5,000,000 $ 0
Advertising expense   $ 1,894 $ 1,493    
Research and development expenses   $ 257,529 $ 296,413 $ 526,769 $ 607,861
Warrants Outstanding [Member]          
Securities Financing Transaction [Line Items]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   105,380,666 250,000    
Options Outstanding [Member]          
Securities Financing Transaction [Line Items]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   3,323,552 3,349,793    
VDA Purchase Agreement [Member]          
Securities Financing Transaction [Line Items]          
Capital contribute $ 5,000,000        
Shre acquisition 162,900,947        
Warrants issued 105,380,666